Why Does GlaxoSmithKline plc Yield So Much More Than AstraZeneca plc?

These two British drugs behemoths are similar businesses that both pay big dividends, and they’ve mostly tended to move in lockstep. However, in recent months GlaxoSmithKline (LSE: GSK) has sported a much higher — and hence more potentially more attractive — yield than AstraZeneca (LSE: AZN). So what’s up? Owain Bennallack investigates…

To find out the strategies to adopt if you want to become one of the growing number of surprise UK millionaires, read this FREE Motley Fool report: '7 Simple Steps For Seeking Serious Wealth' while it remains available!


Owain Bennallack owns shares in GSK and AZN. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.